Antithymocyte Globulin and Cyclosporine to Treat Myelodysplasia

NCT00005937 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

42

Enrollment

NIH

Sponsor class

Conditions

Myelodysplastic Syndrome

Interventions

DRUG: Antithymocyte globulin
DRUG: Cyclosporine

Sponsor

Neal Young, M.D.